Omega Healthcare Investors, Inc. – Consensus ‘hold’ rating and 7.3% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Omega Healthcare Investors, Inc. with ticker code (OHI) now have 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target price and low target price is between $37.00 and $30.00 calculating the mean target price we have $33.27. Given that the stocks previous close was at $31.00 this would indicate that there is a potential upside of 7.3%. The 50 day MA is $32.55 and the 200 day moving average is $30.46. The market capitalization for the company is 7.66B. The current share price for the company is: $30.40 USD

The potential market cap would be $8,220,691,804 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 31.02, revenue per share of $3.60 and a 2.36% return on assets.

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through the segment, which consists of investments in healthcare-related real estate properties located in the United States and the United Kingdom. The Company’s core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). The Company’s portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 926 healthcare facilities, located in 42 states and the United Kingdom that are operated by 67 third-party operators.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search